UK Markets closed

Hikma Pharmaceuticals PLC (HKMPY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
41.89+0.89 (+2.18%)
At close: 12:05PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.16
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 358.32
52-week low 325.12
50-day moving average 338.32
200-day moving average 337.61

Share statistics

Avg vol (3-month) 31.73k
Avg vol (10-day) 3750
Shares outstanding 5115.74M
Implied shares outstanding 6N/A
Float 876.98M
% held by insiders 10.00%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.1
Forward annual dividend yield 43.87%
Trailing annual dividend rate 30.50
Trailing annual dividend yield 31.22%
5-year average dividend yield 41.79
Payout ratio 436.07%
Dividend date 329 Sept 2022
Ex-dividend date 417 Aug 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 13.57%
Operating margin (ttm)21.57%

Management effectiveness

Return on assets (ttm)7.70%
Return on equity (ttm)15.40%

Income statement

Revenue (ttm)2.55B
Revenue per share (ttm)22.27
Quarterly revenue growth (yoy)-0.20%
Gross profit (ttm)1.3B
EBITDA 762M
Net income avi to common (ttm)346M
Diluted EPS (ttm)3.62
Quarterly earnings growth (yoy)-30.20%

Balance sheet

Total cash (mrq)393M
Total cash per share (mrq)3.57
Total debt (mrq)1.55B
Total debt/equity (mrq)70.79
Current ratio (mrq)2.12
Book value per share (mrq)18.53

Cash flow statement

Operating cash flow (ttm)583M
Levered free cash flow (ttm)279.88M